PLATELET TO LYMPHOCYTE RATIO IN NEONATES: A PREDICTOR OF EARLY ONSET NEONATAL SEPSIS

Main Article Content

Birol Karabulut *
Baran Cengiz Arcagok
(*) Corresponding Author:
Birol Karabulut | dr.birolkarabulut@icloud.com

Abstract

Introduction


Neonatal sepsis (NS) is a common systemic disease that causes morbidity and mortality in newborns. But there is no ideal biomarker that can be used in the early diagnosis of NS. In recent studies, platelet width to lymphocyte ratio (PLR)  have been reported to play a critical role in the inflammatory process. In this study, we aimed to contribute to the research about whether or not PLR can be used in the early diagnosis of NS.


Methods


This retrospective cohort study was conducted among the newborns whose born in İzmir Buca Maternity and Pediatric Hospital between March 2015-February 2016. During these twelve months, 611 neonates with EOS were admitted to our neonatal intensive care unit. One hundred and forty-nine neonates with  suspected EOS, 67 neonates with proven EOS and 92 healty neonates were enrolled in the study.


Results


Platelet width lymphocyte (LPR) values of the groups were calculated 56.5 ± 17.8 vs 62.4± 14.9 vs 15.3 ± 2.1 respectively. PLR values of suspected or proven EOS group was significantly higher than the control group. PLR has AUC 0.89 to 0.93, cutoff value of 39.5 to 57.7, sensitivity of 88.9% to 91.3% and specifity of 94.7% to 97.6%, positive predictive value of 94.3% to 97.4%, and negative predictive value of 88.6% to 91.8% in suspected and proven sepsis diagnosis.


Conclusion


Based on our results suggest that PLR can be used as a biomarker predictive of EOS.


Downloads month by month

Downloads

Download data is not yet available.

Article Details

References

Y. Dong, C.P. Speer, Late-onset neonatal sepsis: recent developments,
Arch. Dis. Child. Fetal Neonatal Ed. 100 (3) (2015) F257-F263.
https://doi.org/10.1136/archdischild-2014-306213
PMid:25425653 PMCid:PMC4413803
2. R.A. Polin, F. Committee on, Newborn, Management of neonates with
suspected or proven early-onset bacterial sepsis, Pediatrics 129 (5)
(2012) 1006-1015.
https://doi.org/10.1542/peds.2012-0541
PMid:22547779
3. Cohen J, Vincent JL, Adhikari NKJ, Machado FR, Angus DC, Calandra
T, et al. Sepsis: A roadmap for future research. Vol. 15, The Lancet
Infectious Diseases. 2015. p. 581-614.
https://doi.org/10.1016/S1473-3099(15)70112-X
4. J.S. Gerdes, Diagnosis and management of bacterial infections in the
neonate, Pediatr. Clin. N. Am. 51 (4) (2004) 939-959
https://doi.org/10.1016/j.pcl.2004.03.009
PMid:15275982
5. Mukhopadhyay S, Taylor JA, Von Kohorn I, et al. Variation in sepsis
evaluation across a national network of nurseries. Pediatrics 2017;139(3)
https://doi.org/10.1542/peds.2016-2845
PMid:28179485
6. Mussap M, Noto A, Cibecchini F, Fanos V. The importance of
biomarkers in neonatology. Semin Fetal Neonatal Med. 2013;18:56-64.
https://doi.org/10.1016/j.siny.2012.10.006
PMid:23164809
7. Jyothi P, Basavaraj MC, Basavaraj PV. Bacteriological profile of
neonatal septicemia and antibiotic susceptibility pattern of the isolates. J
Nat Sci Biol Med 2013;4:306-9.
https://doi.org/10.4103/0976-9668.116981
PMid:24082722 PMCid:PMC3783770
8. Benitz WE. Adjunct laboratory tests in the diagnosis of early-onset
neonatal sepsis. Clin Perinatol 2010;37:421-38.
https://doi.org/10.1016/j.clp.2009.12.001
PMid:20569816
9. J.R. Delanghe, M.M. Speeckaert, Translational research and biomarkers
in neonatal sepsis, Clin. Chim. Acta 451 (Pt A) (2015) 46-64.
https://doi.org/10.1016/j.cca.2015.01.031
PMid:25661089
10. Su H, Chang SS, Han CM, et al. Inflammatory markers in cord blood or
maternal serum for early detection of neonatal sepsis-a systemic review
and meta-analysis. J Perinatol 2014;34:268-74.
https://doi.org/10.1038/jp.2013.186
PMid:24457256
11. Zhou M, Cheng S, Yu J, et al. Interleukin-8 for diagnosis of neonatal
sepsis: a meta-analysis. PLoS One 2015;10:e0127170
https://doi.org/10.1371/journal.pone.0127170
PMid:25996378 PMCid:PMC4440704
12. Laborada G, Rego M, Jain A, Guliano M, Stavola J, Ballabh P, et al.
Diagnostic value of cytokines and C-reactive protein in the first 24 hours
of neonatal sepsis. Am J Perinatol. (2003) 20:491-501. doi: 10.1055/s-
2003- 45382 5.
https://doi.org/10.1055/s-2003-45382
PMid:14703598
13. Chiesa C, Pacifico L, Osborn JF, Bonci E, Hofer N, Resch B. Earlyonset
neonatal sepsis: still room for improvement in procalcitonin
diagnostic accuracy studies. Medicine (Baltimore). 2015;94:e1230.
https://doi.org/10.1097/MD.0000000000001230
PMid:26222858 PMCid:PMC4554116
14. Hedegaard SS, Wisborg K, Hvas A-M. Diagnostic utility of biomarkers
for neonatal sepsis-a systematic review. Infect Dis (Lond). 2015;47:117-
124.
https://doi.org/10.3109/00365548.2014.971053
PMid:25522182
15. Wang Z, Peng S, Wang A, Xie H, Guo L, Jiang N, Niu Y. Plateletlymphocyte
ratio acts as an independent predictor of prognosis in
patients with renal cell carcinoma. Clin Chim Acta. 2018 May;480:166-
172. Epub 2018 Feb 17.
https://doi.org/10.1016/j.cca.2018.02.014
PMid:29462592
16. Chen H, Xue H, Liu W, Wu F, Wang Y, Gao H. Meta-analysis of
Platelet Lymphocyte Ratio as A Prognostic Factor for Non-small Cell
Lung Cancer. Zhongguo Fei Ai Za Zhi. 2019 May 20;22(5):289-298.
https://doi.org/10.3779/j.issn.1009-3419.2019.05.05
17. Shen Y, Huang X, Zhang W. Platelet-to-lymphocyte ratio as a
prognostic predictor of mortality for sepsis: interaction effect with
disease severity-a retrospective study. BMJ Open. 2019 Jan
25;9(1):e022896.
https://doi.org/10.1136/bmjopen-2018-022896
PMid:30782690 PMCid:PMC6352809
18. Djordjevic D, Rondovic G, Surbatovic M, Stanojevic I, Udovicic I,
Andjelic T et al. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-
Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet
Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and
Injured Patients: Which Ratio to Choose to Predict Outcome and Nature
of Bacteremia? Mediators Inflamm. 2018 Jul 15;2018:3758068.
eCollection 2018.
https://doi.org/10.1155/2018/3758068
PMid:30116146 PMCid:PMC6079471
19. Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009). Statistical
power analyses using G*Power 3.1: Tests for correlation and regression
analyses. Behavior Research Methods, 41, 1149-1160.
https://doi.org/10.3758/BRM.41.4.1149
PMid:19897823
20. European Medicines Agency (EMA), Report on the Expert Meeting on
Neonatal and Pediatric Sepsis, 2010
21. Celik IH, Demirel FG, Uras N, et al. What are the cut-off levels for IL-6
and CRP in neonatal sepsis? J Clin Lab Anal 2010;24:407-12.
https://doi.org/10.1002/jcla.20420
PMid:21089127
22. Cetinkaya M, Ozkan H, Köksal N, et al. Comparison of serum amyloid
A concentrations with those of C-reactive protein and procalcitonin in
diagnosis and follow-up of neonatal sepsis in premature infants. J
Perinatol 2009;29:225-31.
https://doi.org/10.1038/jp.2008.207
PMid:19078972
23. Abdollahi A, Shoar S, Nayyeri F, Shariat M. Diagnostic Value of
Simultaneous Measurement of Procalcitonin, Interleukin-6 and hs-CRP
in Prediction of Early-Onset Neonatal Sepsis. Mediterr J Hematol Infect
Dis. 2012;4:e2012028.
https://doi.org/10.4084/mjhid.2012.028
PMid:22708043 PMCid:PMC3375671
24. Ng PC, Lam HS. Diagnostic markers for neonatal sepsis. Curr Opin
Pediatr. 2006;18:125-31
https://doi.org/10.1097/01.mop.0000193293.87022.4c
PMid:16601490
25. Hofer N, Zacharias E, Müller W, Resch B. An update on the use of Creactive
protein in early-onset neonatal sepsis: current insights and new
tasks. Neonatology. 2012;102:25-36
https://doi.org/10.1159/000336629
PMid:22507868
26. Aydemir C, Aydemir H, Kokturk F, Kulah C, Mungan AG. The cut-off
levels of procalcitonin and C-reactive protein and the kinetics of mean
platelet volume in preterm neonates with sepsis. BMC Pediatr. 2018; 18:
253.
https://doi.org/10.1186/s12887-018-1236-2
PMid:30068303 PMCid:PMC6090766
27. Fendler WM, Piotrowski AJ. Procalcitonin in the early diagnosis of
nosocomial sepsis in preterm neonates. J Paediatr Child Health.
2008;44(3):114-8.
https://doi.org/10.1111/j.1440-1754.2007.01230.x
PMid:17927729
28. Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF,
Pacifico L. Reliability of procalcitonin concentrations for the diagnosis
of sepsis in critically ill neonates. Clin Infect Dis. 1998;26(3):664-72.
https://doi.org/10.1086/514576
PMid:9524841
29. Gendrel D, Assicot M, Raymond J, Moulin F, Francoual C, Badoual J,
Bohuon C. Procalcitonin as a marker for the early diagnosis of neonatal
infection. J Pediatr. 1996;128(4):570-3.
https://doi.org/10.1016/S0022-3476(96)70374-8
30. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin
as an early marker of infection in neonates and children. Lancet Infect
Dis. 2004;4(10):620-30
https://doi.org/10.1016/S1473-3099(04)01146-6
31. Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J.
Procalcitonin and C-reactive protein levels in neonatal infections. Acta
Paediatr. 1997;86:209-12.
https://doi.org/10.1111/j.1651-2227.1997.tb08870.x
PMid:9055895
www.mjhid.org Mediterr J Hematol Infect Dis 2019; 11; e2019055 Pag. 8 / 8
32. Lapillonne A, Basson E, Monneret G, Bienvenu J, Salle BL. Lack of
specificity of procalcitonin for sepsis diagnosis in premature infants.
Lancet. 1998;351: 1211-2.
https://doi.org/10.1016/S0140-6736(05)79165-0
33. Chiesa C, Panero A, Rossi N, Stegagno M. Reliability of procalcitonin
concentrations for the diagnosis of sepsis in critically ill neonates. Clin
Infect Dis. 1998;26:664-72.
https://doi.org/10.1086/514576
PMid:9524841
34. Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos
G, Azoulay E, Chakrabarti A, Kett D, Leon C, Ostrosky-Zeichner L,
Sanguinetti M, Timsit JF, Richardson MD, Shorr A, Cornely OA.
Intensive care medicine research agenda on invasive fungal infection in
critically ill patients. Intensive Care Med. 2017.
https://doi.org/10.1007/s00134-017-4731-2
PMid:28255613
35. Altunhan H, Annagür A, Örs R, Mehmetoğlu I. Procalcitonin
measurement at 24 hours of age may be helpful in the prompt diagnosis
of early-onset neonatal sepsis. Int J Infect Dis. 2011;15:e854-8.
https://doi.org/10.1016/j.ijid.2011.09.007
PMid:22019570
36. Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood
cell count in early-onset neonatal sepsis. Pediatr Infect Dis J.
2012;31:799-802.
https://doi.org/10.1097/INF.0b013e318256905c
PMid:22531231 PMCid:PMC3399972
37. Murphy K, Weiner J. Use of leukocyte counts in evaluation of earlyonset
neonatal sepsis. Pediatr Infect Dis J. 2012;31:16-19.
https://doi.org/10.1097/INF.0b013e31822ffc17
PMid:21860335
38. Shaaban HA, Safwat N. Mean Platelet Volume in Preterm: A Predictor
of Early Onset Neonatal Sepsis. J Matern Fetal Neonatal Med.
2018;22:1-6.
https://doi.org/10.1080/14767058.2018.1488161
PMid:29886794
39. Patrick CH, Lazarchick J. The effect of bacteremia on automated platelet
measurement in neonates. Am J Clin Pathol. 1990;93:391-4.
https://doi.org/10.1093/ajcp/93.3.391
PMid:2309660
40. Zang HB, Chen J, Lan FQ, Ma XJ, Zhang SY. Diagnostic values of red
cell distribution width, platelet distribution width and
neutrophil-lymphocyte count ratio for sepsis. Experimental and
Therapeutic Medicine. 2016;12:2215-2219.
https://doi.org/10.3892/etm.2016.3583
PMid:27698714 PMCid:PMC5038364
41. Elawady S, Botros SK, Sorour AE, et al. Neutrophil CD64 as a
Diagnostic Marker of Sepsis in Neonates. J Investig Med 2014;62:644-9.
https://doi.org/10.2310/JIM.0000000000000060
PMid:24463977
42. Yoon NB, Son C, Um SJ. Role of the neutrophil-lymphocyte count ratio
in the differential diagnosis between pulmonary tuberculosis and
bacterial community-acquired pneumonia. Ann Lab Med. 2013;33:105-
110
https://doi.org/10.3343/alm.2013.33.2.105
PMid:23482854 PMCid:PMC3589634
43. Can E, Hamilcikan Ş, Can C. The Value of Neutrophil to Lymphocyte
Ratio and Platelet to Lymphocyte Ratio for Detecting Early-onset
Neonatal Sepsis. J Pediatr Hematol Oncol. 2018 May;40(4):e229-e232.
https://doi.org/10.1097/MPH.0000000000001059
PMid:29219889